Sublingual tablets of house dust mite allergen extracts: Results of a phase I study in adults with mite-associated allergic asthma

R. K. Zeldin, P. Demoly, P. Betting, P. Rodriguez, A. Racaud, M. Le Gall (Antony, Montpellier, Paris, France)

Source: Annual Congress 2013 –Studies of asthma in man
Session: Studies of asthma in man
Session type: Poster Discussion
Number: 3157
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. K. Zeldin, P. Demoly, P. Betting, P. Rodriguez, A. Racaud, M. Le Gall (Antony, Montpellier, Paris, France). Sublingual tablets of house dust mite allergen extracts: Results of a phase I study in adults with mite-associated allergic asthma. Eur Respir J 2013; 42: Suppl. 57, 3157

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High doses of sublingual tablets of house dust mite allergen extracts: Lung function assessment in a phase I study in adults with mite-associated allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015


Collaborative treatment with variety of dust mites allergic in standardized dermatophagoides pteronyssinus allergen immunotherapy
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016


Safety of 5-grass pollen extract sublingual tablet in patients with grass pollen-induced allergic rhinoconjunctivitis and concomitant intermittent asthma: A pooled analysis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

Safety of subcutaneous immunotherapy with standardized extracts of house dust mite in allergic asthmatic subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 57s
Year: 2002

LSC 2014 abstract - Influenza-induced exacerbation in a murine chronic house dust mite (HDM) asthma model
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014

Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Efficacy of specific allergy vaccination in house dust mite asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 465s
Year: 2005

Prevention of paediatric asthma and allergy by reduction of house dust mite content
Source: Eur Respir J 2001; 18: Suppl. 33, 287s
Year: 2001

Late Breaking Abstract - Budget impact of introducing 12SQ HDM SLIT-tablet for house dust mite allergic asthma in Spain
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019

Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


Clinical efficiency of sublingual and subcutaneous allergenspecific immunotherapy with household dust mite allergen in patients with persistent allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 438s
Year: 2006

Bacteria and mould components in house dust and children's allergic sensitisation
Source: Eur Respir J 2007; 29: 1144-1153
Year: 2007



Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma whether due to seasonal allergens or to perennial allergens
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Year: 2020


OPURIT: Omalizumab-protected ultra rush specific immunotherapy in severe asthmatic patients with house dust mite allergy
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011


Effects of airborne pollen levels on drug consumption for seasonal allergic rhinoconjunctivitis: A ten-year French study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Diagnostic utility of serum periostin for house dust mite sublingual immunotherapy response in allergic rhinitis
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021


Dynamic change of house dust mites and its components- sIgE and sIgG4 in specific immunotherapy
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


The effect of anti-mite mattress covers on mite allergen levels in the PIAMA (prevention and incidence of asthma and mite allergy) study
Source: Eur Respir J 2001; 18: Suppl. 33, 321s
Year: 2001

House dust mite (HDM) avoidance and treatment of severe childhood asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 314s
Year: 2003